Publication

Article

Cardiology Review® Online

September 2008
Volume25
Issue 9

Successful PCI in an elderly woman

A 75-year-old woman who experienced chest discomfort that caused her to awaken and persisted as retrosternal pain was admitted to the emergency department.

A 75-year-old woman who experienced chest discomfort that caused her to awaken and persisted as retrosternal pain was admitted to the emergency department. Her medical history included arterial hypertension, diabetes, hypercholesterolemia, and a 50-pack-year history of cigarette smoking, but she had no history of major medical events. Her drug regimen consisted of a once-daily dose of aspirin (100 mg), metoprolol (50 mg), felodipine (5 mg), and simvastatin (20 mg), and a twice-daily dose of gliclazide (40 mg).

On physical examination, she had dyspnea and appeared uncomfortable. Her respiratory rate was 25 breaths per minute, her oxygen saturation was 88% on room air, and her blood pressure was 170/90 mm Hg. Auscultation of her chest revealed crackles in the lungs and a regular rhythm with an S4 gallop. Cardiomegaly and bilateral edema were documented by a chest radiograph. An electrocardiogram showed a left bundle branch block, and blood tests indicated elevated levels of total creatinine kinase and troponin T. Echocardiography documented a markedly reduced ejection fraction of 0.40, based on an anterolateral hypokinesia with dilated left ventricle.

In the emergency department, the patient received furosemide, nitroglycerin, clopidogrel, and low-molecular-weight heparin. Subsequent coronary angiography demonstrated 3-vessel disease. Approximately 5 hours after her symptoms started, the patient underwent percutaneous coronary intervention (PCI). During the procedure, 2 bare metal stents were deployed in the left anterior descending artery and 1 drug-eluting stent was deployed in the right coronary artery. The patient was discharged from the hospital with a 12-month prescription for clopidogrel 75 mg daily.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
Erin Michos, MD: HFpEF in Women and Sex-Specific Therapeutic Approaches | Image Credit: Johns Hopkins
© 2024 MJH Life Sciences

All rights reserved.